Novo Nordisk has stopped two trials of a drug that aims to tame inflammation as a way to improve cardiovascular health, ...
Tara covers the business of health care. Her stories focus on hospitals, doctors, and how their business practices affect patients — especially when private equity gets involved. She also writes about ...
The American Diabetes Association “continues to move from crisis to crisis to crisis,” says one of five members ejected from ...
A closely watched cardiovascular drug from Novartis failed in a pivotal study, the company said Friday, a major blow to the ...
The whole of my field has been flattened into a single lazy question: Did the health care system fail her?” writes Jennifer ...
Two recipients of gene-edited pig kidneys have successfully received human organs, a milestone in the wider effort to advance ...
Experts agreed that the biggest threat to progress on overdose deaths is the looming Medicaid cuts. Researchers at Penn’s ...
Today, a look at how some generative AI medical devices are getting on the market quickly. Plus: OpenEvidence’s new AI models ...
Ultragenyx drug fails pivotal Phase 3, FDA's success at regulating unproven stem cells, and other biotech news ...
At a "practice of last resort," pediatricians prioritize allaying parents' vaccine concerns without hardline dismissals.
W WASHINGTON — Hospital leaders, stung by the passage of a law that will cut nearly $1 trillion in Medicaid funding over the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results